Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ECE1 | P42892 | 4/20 | 0.42 |
| ▸ | PDCD1LG2 | Q9BQ51 | 1/20 | 0.32 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.32 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.31 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.31 |
| ▸ | ITGAL | P20701 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7034111 | 1.00 | ECE1 (0.42) | ECE1PDCD1LG2CD274ITGB2ICAM1 | |
| Benzene SCHEMBL28092853 | 0.94 | ECE1 (0.39) | ECE1PDCD1LG2CD274ITGB2ICAM1 | |
| SCHEMBL88480 | 0.84 | ECE1 (0.46) | ECE1PDCD1LG2CD274ITGB2ICAM1 | |
| SCHEMBL30406637 | 0.84 | ECE1 (0.46) | ECE1PDCD1LG2CD274ITGB2ICAM1 | |
| SCHEMBL8450154 | 0.84 | ITGB3 (0.34) | CA2 | |
| SCHEMBL17773049 | 0.84 | ITGB3 (0.34) | CA2 | |
| SCHEMBL88481 | 0.84 | ECE1 (0.46) | ECE1PDCD1LG2CD274ITGB2ICAM1 | |
| Phenol SCHEMBL2640784 | 0.83 | ALDH1A1 (0.40) | ITGB2ICAM1ITGAL | |
| Phenol SCHEMBL28162156 | 0.83 | ALDH1A1 (0.40) | ITGB2ICAM1ITGAL | |
| Phenol SCHEMBL1847412 | 0.83 | ALDH1A1 (0.40) | ITGB2ICAM1ITGAL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 212 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2106279-A2 | STATIONARY PHASE GRADIENT CHROMATOGRAPHY | Cryobiophysica, Inc. (US) | 2009-10-07 | — | — | EP | claimed |
| US-20080179243-A1 | Stationary Phase Gradient Chromatography | HIRSH ALLEN | 2008-07-31 | — | — | US | claimed |
| WO-2008086357-A2 | STATIONARY PHASE GRADIENT CHROMATOGRAPHY | CRYOBIOPHYSICA, INC. (US) | 2008-07-17 | — | — | WO | claimed |
| US-20260137647-A1 | COMPOSITIONS AND METHODS FOR TREATING INSOMNIA | AXSOME THERAPEUTICS INC (US) | 2026-05-21 | — | — | US | disclosed |
| EP-4743071-A2 | DIPHENYLETHYLENE COMPOUNDS AND COMPOSITIONS THEREOF | INNOVENE INC. (US) | 2026-05-20 | — | — | EP | disclosed |
| US-20260116901-A1 | PSILOCIN DERIVATIVES AS SEROTONERGIC PSYCHEDELIC AGENTS FOR THE TREATMENT OF CNS DISORDERS | MINDSET PHARMA INC. (CA) | 2026-04-30 | — | — | US | disclosed |
| US-12606543-B2 | Indole derivatives as serotonergic agents useful for the treatment of disorders related thereto | MINDSET PHARMA INC. (CA) | 2026-04-21 | — | — | US | disclosed |
| EP-4724066-A1 | INOSINE MONOPHOSPHATE DEHYDROGENASE (IMPDH) INHIBITORS FOR THE TREATMENT AND PREVENTION OF BRAIN METASTASIS OF A CANCER | McMaster University (CA) | 2026-04-15 | — | — | EP | disclosed |
| US-20260092035-A1 | INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | MINDSET PHARMA INC (CA) | 2026-04-02 | — | — | US | disclosed |
| US-20260083703-A1 | INDOLINE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | MINDSET PHARMA INC (CA) | 2026-03-26 | — | — | US | disclosed |
| US-20260069726-A1 | ZWITTERIONIC COMPOUNDS AND USES THEREOF | UNIV SASKATCHEWAN (CA) | 2026-03-12 | — | — | US | disclosed |
| CN-102642894-B | Drive solute, the positive permeating method driving solution, water treatment facilities and water to process | 三星电子株式会社 | 2016-08-03 | — | — | CN | disclosed |
| CN-101801421-B | Containing launching the compositions of inorganic particle of positron and the application especially for diagnostic procedure in medical science thereof | NANOPET PHARMA GMBH (DE) | 2016-01-20 | — | — | CN | disclosed |
| EP-2106279-A2 | STATIONARY PHASE GRADIENT CHROMATOGRAPHY | Cryobiophysica, Inc. (US) | 2009-10-07 | — | — | EP | disclosed |
| CN-101405019-A | Medicine for treating tumor and application thereof | UNIV TSINGHUA (CN) | 2009-04-08 | — | — | CN | disclosed |
| US-20080179243-A1 | Stationary Phase Gradient Chromatography | HIRSH ALLEN | 2008-07-31 | — | — | US | disclosed |
| WO-2008086357-A2 | STATIONARY PHASE GRADIENT CHROMATOGRAPHY | CRYOBIOPHYSICA, INC. (US) | 2008-07-17 | — | — | WO | disclosed |
| US-20040236091-A1 | Translational profiling | EISAI INC. | 2004-11-25 | — | — | US | disclosed |
| WO-2002078524-A2 | TRANSLATIONAL PROFILING | ZYCOS INC. (US) | 2002-10-10 | — | — | WO | disclosed |
| US-6184336-B1 | USEFUL AS CHELANTS IN WATER TREATMENT | NALCO CHEMICAL COMPANY | 2001-02-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260069726-A1 | ZWITTERIONIC COMPOUNDS AND USES THEREOF | CA13, SLCO2B1, SLCO2A1 | ECE1 2974/4885PDCD1LG2 3590/4885CD274 2337/4885 |
| US-20260137647-A1 | COMPOSITIONS AND METHODS FOR TREATING INSOMNIA | HCRTR1, HCRTR2, CNR1 | ECE1 3337/4885PDCD1LG2 4731/4885CD274 4269/4885 |
| US-20260116901-A1 | PSILOCIN DERIVATIVES AS SEROTONERGIC PSYCHEDELIC AGENTS FOR THE TREATMENT OF CNS DISORDERS | HTR6, CNR1, HTR2C | ECE1 4417/4885PDCD1LG2 4513/4885CD274 4660/4885 |
| US-20260092035-A1 | INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | HTR6, HTR3C, CNR1 | ECE1 3323/4885PDCD1LG2 4580/4885CD274 4456/4885 |
| US-12606543-B2 | Indole derivatives as serotonergic agents useful for the treatment of disorders related thereto | HTR6, CNR1, HTR3C | ECE1 3426/4885PDCD1LG2 4480/4885CD274 4656/4885 |
| US-20260083703-A1 | INDOLINE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | HTR6, HTR1A, HTR2C | ECE1 1547/4885PDCD1LG2 4692/4885CD274 4694/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.